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ABSTRACT Voltagejump and light-flash experiments have been performed
on isolated Electrophorus electroplaques exposed simultaneously to nicotinic
agonists and to the photoisomerizablecompound 2,2'-bis-[a-(trimethylammon-
ium)methyl]-azobenzene (2BQ) . Dose-response curves are shifted to the right
in a nearly parallel fashion by 2BQ, which suggests competitive antagonism ;
dose-ratio analyses show apparent dissociation constants of 0.3 and 1 /.M for
the cis and trans isomers, respectively . Flash-induced trans --+ cis concentration
jumps produce the expected decrease in agonist-inducedconductance; the time
constant is several tens of milliseconds . From the concentration dependence of
these rates, we conclude that the association and dissociation rate constants for
the cis-2BQ-receptor bindingare ^-10$M- ' s-' and 60 s-' at 20 °C; the QIo is 3 .
Flash-induced cis -+ trans photoisomerizations produce molecular rearrange-
ments of the ligand-receptor complex, but the resulting relaxations probably
reflect the kinetics of buffered diffusion rather than of the interaction between
trans-2BQ and the receptor . Antagonists seem to bind about an order of
magnitude more slowly than agonists at nicotinic receptors .
INTRODUCTION
According to present concepts of competitive antagonism at nicotinic receptors,
d-tubocurarine and related drugs interact directly with the agonist site ; this
occupation prevents the binding of agonists and the resulting activation of the
channel . Most electrophysiological studies suggest that the antagonist-receptor
interaction is characterized byasingle dissociation constant of^-10-' M, although
more recent binding studies reveal two separate binding reactions whose associ-
ation constants flank this value (Neubig and Cohen, 1979 ; Sine and Taylor,
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1981). This paper is concerned with the kinetics of the antagonist-receptor
interaction.
Hill (1909) first studied the response to a sudden change of tubocurarine
concentration in the solution bathing a frog muscle. Although he hoped to
determine the molecular rates of the antagonist-receptor interaction, the mea-
surements were limited by the drug's diffusion into the muscle rather than by
the molecular rates of interest. del Castillo and Katz (1957) measured the
responses to brief iontophoretic pulses ofboth antagonist and agonist from twin
pipettes onto the same synapse. In their experiments, tubocurarine's inhibitory
effect decayed over several seconds, much more slowly than expected from the
diffusion of tubocurarine in solution. It was suggested that this slow recovery
represented the molecular rate of dissociation of the tubocurarine-receptor
complex. Less direct experiments have since suggested much faster rates (Black-
man et al., 1975; Sheridan and Lester, 1977; Colquhoun et al., 1979), and it has
been shown that the iontophoresis experiment was distorted by the phenomenon
of buffered diffusion within the synaptic cleft: tubocurarine's macroscopic rate
ofaction is at least an order ofmagnitude slower than its molecular binding rates
because its rate of diffusion is slowed by high-affinity binding to its receptors
(Armstrong and Lester, 1979).
Other relaxation techniques have been of limited use for kinetic data on the
antagonist-receptor interaction. The binding is not thought to be voltage-sensi-
tive, so that voltage jumps couple only indirectly to this interaction and are
instead dominated by the voltage-dependent processes of(a) channel gating and
(b) open channel blockade by the antagonist (Manalis, 1977; Colquhoun et al.,
1979). Single channel measurements would be complicated by (a) multiple closed
states of the receptor and (b) channel gating produced by the antagonists
themselves (Trautmann, 1982; Morris et al., 1983); this activation might not
involve the same binding mechanisms as the competitive antagonism.
The light-flash technique (Lester and Chang, 1977; Lester and Nerbonne,
1982) does enable the experimenter to jump the concentration of ligand within
the synaptic cleft. Although the prototypical competitive antagonist d-tubocurar-
ine is not photosensitive, 2,2'-bis-[a-(trimethylammonium)methyl]azobenzene
(2BQ) (Fig. 1) is photoisomerizable and displays competitive antagonism. The
apparent dissociation constant is similar to that for d-tubocurarine (Lester et al.,
1980). The present study was therefore undertaken to measure directly the rate
constants for the antagonist-receptor interaction. The data have already been
presented briefly in abstract form (Krouse et al., 1982, 1984) and as part of a
Ph.D. dissertation (Krouse, 1984).
METHODS
Reagents
trans-2BQ was synthesized as described (Wassermann and Erlanger, 1981). The pure cis
isomer was obtained by exposing a nearly saturated solution (2 mM) to ultraviolet (UV)
light, followed by high-performance liquid chromatography (Nerbonne et al., 1983).
Tetrodotoxin and the agonists (acetylcholine, carbachol, and suberyldicholine) were
purchased from Sigma Chemical Co., St. Louis, MO.KROUSE ET AL.
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Electrophysiology
In a typical experiment,5-11 applicationsofagonist and numerous washes were completed
on a single isolated electroplaque in an apparatus similar to that described by Sheridan
and Lester (1977). Two preliminary agonist applications were performed to check the
reproducibility of the agonist-induced currents and to provide a measure of the time of
diffusion of agonist molecules from pool A (the solution bathing the innervated face) to
receptors. During subsequent agonist applications, voltagejump episodes were recorded
after the estimated diffusion time had elapsed. After each agonist application, the solution
in pool A was exchanged for Ringer three times over a period of 5 min. At the end of
the wash cycles, agonist-induced currents had disappeared. For measurements of agonist-
induced currents in the presence of 2BQ, pool A was preincubated with 2BQ alone for
300 400 500
X(nm)
FIGURE 1.
￿
Structure of 2BQ and optical absorption spectra of the cis and trans
isomers. The absorption maximum of the trans isomer is at 327 nm (e = 1 .9 x 10'
1/mol-cm); an isosbestic point is observed at 287 nm (e = 0.54 x 10' 1/mol-cm).
5-10 min. After trials in agonist and 2BQ, pool A was washed several times with Ringer
over 15 min. All experiments in the presence of 2BQ were preceded and followed by
trials with agonist alone. Agonist-induced currents were measured by subtraction of the
passive membrane responses; as detailed in previous publications, these passive responses
could be isolated either in trials without agonist or, in the presence of agonist, by evoking
voltage jumps in a region of membrane potential where the agonist-induced conductance
is negligible (Sheridan and Lester, 1977).
Rate constants were measured for the relaxations in response to both voltage jumps
and light flashes. Voltagejump relaxations could usually be described with a single
exponential, using a least-squares fit to the semilogarithmic plot of the approach to steady
state (Figs. 9 and 10). Some voltagejump relaxations, and most light-flash relaxations,
required two exponentials; these were fit by the method of least squares.238
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Photochemistry
The thermal cis-trans isomerization of2BQ in solution is negligibly slow at or below room
temperature. The two isomers interconvert in the presence of light; the mole fraction of
each isomer in a solution depends on the wavelength of irradiation. This mole fraction is
determined from the optical spectra of the solutions by linear interpolation between the
A327/A281 ratios for the pure isomers (cf. Fig. 1). These concepts are used to measure the
potency of a given flash for trans --+ cis and cis -> trans photoisomerization (Nass et al.,
1978; Lester and Nerbonne, 1982 ; Sheridan and Lester, 1982). Table I presents the
photoisomerization potencies for the filters and flashes used with 2BQ in the experiments.
We often employed a predominantly trans or cis photostationary solution (TPSS or CPSS,
respectively), obtained by prolonged irradiation either with unfiltered flashes (TPSS, 80%
trans) or with a 365-nm lamp (CPSS, 85% cis).
The optical arrangement was similar to that previously described (Nass et al., 1978).
There were two improvements: (a) the xenon short-arc flash tube was placed at one focus
of a polished ellipsoidal mirror rather than in a standard lamp housing; and (b) the energy
storage bank had a capacitance of 2,100,uF and was charged to 450 V. The flash intensity
rose to a peak in <100 us and fell with a time constant of 500 jus. This arrangement
Simulations
RESULTS
Equilibrium Measurements
TABLE I
Photoisomerization Potenciesfor 2BQ with the Filters Used
yielded a fivefold increase in the UV light intensity at the preparation, as compared with
the previous apparatus (Nass et al., 1978).
Light from the flash-lamp was filtered to remove h < 290 nm (WG 295, Schott Optical
Glass, Inc., Duryea, PA) and focused on the preparation with a quartz lens (focal length,
75 mm ; numerical aperture, 0.16) (Nargeot et al., 1982). Filters were placed in the light
path between the ellipsoidal mirror and the focusing lens.
A few experiments required briefer flashes; these were delivered at 440 nm with the
flash-lamp-pumped dye laser described by Sheridan and Lester (1982).
Numerical simulations of the relaxations were performed with the TUTSIM program
(Applied i, Palo Alto, CA), which integrates linear differential equations.
In Electrophorus electroplaques, steady state agonist-induced conductances are
conveniently measured during hyperpolarizing voltage jumps (Sheridan and
Filter
341 interference
X (± Half-width at
half-maximum)
nm
341±10
isomerization
/k
flash-'
0.02
potency
k
0.18
UG11 (UV) 328±47 0.09 0.51
UGI (UV) 362±33 0.23 0.55
BG3 (blue) 400±55 0.60 0.40
No filter 300-800 2.40 0.60
OG550 (orange) >550 <0.01 <0.01KROUSE ET AL.
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Lester, 1975, 1977). Our experiments employed the three agonists suberyldi-
choline(Fig. 2), carbachol, andacetylcholine. Results with agonistalone generally
agreed with previous studies showing that steady state conductances increase
with increasing agonist concentration and with more negative membrane poten-
tial (Adams, 1975; Neher and Sakmann, 1975; Sheridan and Lester, 1975,
1977). 2BQ induces no detectable conductance by itself, but it does block agonist-
induced conductances.
Dose-ratio studies were performed in order to characterize the 2BQ-receptor
interaction. In such experiments, one measures steady state conductances at
several agonist concentrations in thepresence of varyingconcentrations of 2BQ,
and from these data abbreviated log-dose response curves are constructed (Fig.
3). Concentrations were selected to give agonist-induced conductances between
log scale
a
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FIGURE 2.
￿
Superimposed agonist-induced currents from three different voltage-
clamp trials during a dose-ratio experiment with 2BQ and suberyldicholine at 6°C.
Passive and capacitive currents have been subtracted. In each episode, the voltage
was stepped from +60 to -150 mV 4 ms after the start. The agonist-induced
current approached a new steady state value along an approximately exponential
time course (semilog plots are shown at the top; the boxes define a 10-fold range of
current). Trace a: 10 uM suberyldicholine plus 2 uM 2BQ (trans-photostationary
state); b: 3 uM suberyldicholine; c: 10 AM suberyldicholine. See text for a discussion
of the rate constants. Experiment 427T39 .
30 and 60% of the maximal response. The measure of interest is the ratio of
agonist concentrations giving equal steady state conductance levels in the pres-
ence and absence of 2BQ. With 2BQ at concentrations of <-4.0 uM, dose-
response curves were shifted to higher agonist concentrations with no change in
slope, and 2BQ did not decrease the maximum agonist-induced current at high
agonist concentrations (Krouse, 1984). Under these conditions, 2BQ therefore
behaves as a competitive antagonist. At concentrations of >4 uM, 2BQ did exert
noncompetitive blockade; this action is discussed more fully below.
From the dependence of the dose ratio on 2BQ concentration, one obtains an
apparent dissociation constant Ki of 0.7 uM for the trans-photostationary state
(Fig. 4). As found previously for d-tubocurarine (Lester et al., 1975), this value
wasthe same for all voltages in the range tested (-60 to -150 mV), which implies240
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FIGURE 3.
￿
Abbreviateddose-response plots, showing inhibition ofAgonist-induced
currents by 2BQ. Data are from voltage-clamp trials like those of Fig. 2. Agonist,
carbachol;antagonist, 2BQ (trans-photostationary state). Voltage, -120 mV; 20°C.
Means t SEM from measurements on four cells. TPSS-2BQ concentrations: ", 0.0
jM; O, 1.0 wM; A, 2.0 kM; A, 3.0 uM; ", 4.0 kM; 0, 6.0,M.
that the apparent affinity of 2BQ for the receptor is voltage-independent. It
should be noted that the assumptions of the dose-ratio method may be inappro-
priate for nicotinic acetylcholine receptors. The Discussion contains a more
detailed evaluation of the shape of the dose-ratio plot.
The most interesting result ofthe dose-ratio studies wasof course the variation
in inhibition with the isomeric composition of the 2BQ solution . One would
expect the apparent affinity constant 1/K; to depend linearly on the mole fraction
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[TPSS-2BQ] (j,M)
FIGURE 4.
￿
Dose-ratio analysis of experiments like those of Figs. 2 and 3. The line
is a weighted least-squares fit to all the data at 2BQ concentrations of 54 'M,
constrained to pass through the point (0, 1). The data for individual voltages give
slopes differingby <5%. The intercepton theconcentration axis gives the apparent
dissociation constant (K; = 0.7 IAM). ", -70 mV; O, -100 mV; A, -130 mV. See
text for further information.KROUSE ET AL.
￿
Rates and Equilibriafor Nicotinic Antagonist
￿
24 1
of each isomer; therefore, it is more revealing to plot this parameter than Ki
(Fig. 5). The pure cis isomer has an equilibrium binding constant of 0.33 AM for
the receptor; the pure trans isomer binds one-third as strongly.
Kinetic Measurements: Voltagejump Relaxations
Although the voltagejump experiments described above were designed primarily
to give information about equilibrium binding properties, they also gave prelim-
inary kinetic information. In the experiment of Fig. 2, for instance, the presence
of 2BQ caused a reduction of agonist-induced conductance, but there was little
or no change in the rate constant of the voltagejump relaxation. This suggests
that the blockade re-equilibrates more slowly than the time scale of the voltage-
jump relaxation. We therefore expected that more direct experiments, based on
flash-induced concentration jumps of 2BQ, would reveal a distinct component
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FIGURE 5.
￿
Isomeric dependence of the affinity constant, from data like those of
Figs. 2-4. Each point represents the mean t SEM ofmeasurements on four different
cells.
caused by the 2BQ-receptor interaction on a time scale slower than the agonist-
receptor interaction. This expectation was confirmed.
UV FLASHES
￿
In solutions containing mostly trans-2BQ, UV light increases
the mole fraction of cis in solution. This "antagonist concentration jump" leads
to a net decrease in the conductance and provides the clearest data on the kinetics
of the interaction between cis-2BQ and the receptor.
The typical UV-flash relaxation (Fig. 6) consists of two components. The faster
component, termed Irf, is either a delay (period of zero slope) or a small increase
in agonist-induced current; it is best seen under different conditions and will
therefore be described later. The slower component, 21-f, is the decrease in
agonist-induced current expected to accompany an increase in the antagonist
concentration . The point of greatest interest is that this decrease occurred on a242
time scale roughly one order of magnitude slower than the voltagejump relax-
ations thought to reflect primarily the agonist-receptor interaction.
Our experiments were guided by the idea that component 2,-f is dominated
by the molecular kinetics of the interaction between cis-213Q and the nicotinic
receptor. Several detailed models are presented in the Discussion; for present
purposes, we employ the simple equation
_mA
cm2
8
mA
0.5 C m2
J
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￿
cis-2BQ-R.
k_
I/Ti- = 196s'
y
1/,,,_I= 182 S
1
￿
I
￿
I
￿
1
￿
1
￿
1
0 100 200 300 400 500
Ms
FIGURE 6.
￿
A UV-flash relaxation during a voltage-clamp trial. At the start of the
trial, 2BQ is present in the trans-photostationary state(2 1M); the agonist is carbachol
(500 ;LM). The trial consists of three episodes at intervals of 3 s. Panel A shows
agonist-induced currents; passive and capacitive currents have been subtracted. 50
Ins after the start of each episode, the voltage was jumped from +60 to -150 mV.
As in the experiment of Fig. 2, the agonist-induced current approached a new
steady state value along an approximately exponential time course. The rate
constants for these voltagejump relaxations are 150-200 s-'. Because the time scale
is five times longer than that of Fig. 2, the traces also show a slow decrease in
agonist-induced current, presumably caused by open channel block by 2BQ (see
text). The flash was delivered at the arrow in the second episode, jumping the cis-
2BQ concentration from 0.4 to 0.98 1M. After an initial delay of a few milliseconds
(see text), the conductance decreased with a rate constant of ^-25 s'. Panel B
presents the difference between traces 2 and 3 at higher gain to show the UV-flash
relaxation. Temperature, 6° C. Experiment 1122T24.
For Scheme 1, the relaxation rate constant for component 21- f is expected to
equal the sum k_ + fk+[cis-2BQ]. The dissociation rate constant k_ would
dominate at low 2BQ concentrations; at higher concentrations, the relaxation
rate constant would be determined by the forward binding rate fk+[cis-2BQ].
The factorf, which is between 0 and 1, decreases with agonist concentration and
reflects the more rapidly equilibrating occupancy of binding sites by the agonist;KROUSE ET AL.
￿
Rates and Equilibriafor Nicotinic Antagonist
￿
243
this occupancy effectively reduces the probability of forming the cis-2BQ-recep-
tor complex. The most important evidence for the view that Scheme 1 dominates
the kinetics is the behavior ofcomponent 2,-f asa function ofdrug concentration
(Fig. 7). As expected, (a) 1/r for component 21f increases with 2BQ concentra-
tion, and (b) this increase is less steep with increased agonist concentration.
0
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after flash
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FIGURE 7 .
￿
Relaxation rate constants vs. [cis-2BQ]. Dataare from experiments like
that ofFig. 6, at various concentrations of2BQ and carbachol. The lines are least-
squares fits to the data. (A) 6°C. Data at 150 ([1) and 250 (0) 'UM carbachol are
from the same cell. 0, 400 AM carbachol. (B) 20°C. O, 150 juM carbachol; ", 400
'UM.
The data of Fig. 7 thus allow preliminary estimates of the rate constants for
association and dissociation ofcis-213Q. From the zero-concentration intercepts,
one obtains dissociation rate constants k_ of 10.7 ± 0.8 s-1 (mean ± SD, 6 cells)
at 6'C and 60.4 ± 13.9 s' (17 cells) at 20*C. These intercepts did not change
with voltage over the range -90 to -150 mV. From the slope of the steepest
line at each temperature, one can conclude that the forward binding rates are at244
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least 2 X 107 M-1 s-' at 6'C and at least 7 X 107 M-' s-1 at 20"C. The Discussion
contains a more complete treatment ofthe factorf, allowing for better estimates
of the forward binding rate constants.
ALTERNATIVE EXPLANATIONS
￿
Because our strategy relies so heavily on the
interpretation of component 21f, it is well to emphasize how the observations
rule out alternative explanations. For instance, is component 21-f dominated by
buffered diffusion? The UVflash increases the cis-2BQconcentrationboth within
the synaptic cleft and in the external solution. However, the synaptic cleft has
such a high receptor concentration that equilibrium inhibition might be estab-
lished only after cis-2BQ molecules diffuse into the cleft from the external
solution. This diffusion would be slowed by repeated antagonist binding (Arm-
strong and Lester, 1979). Two observations argue against buffered diffusion in
our experiments. (a) Buffering would be reduced by decreasing the number of
binding sites for 2BQ (Armstrong and Lester, 1979), for instance by increasing
the agonist concentration. However, the relaxation rateconstants decreased with
increasing agonist concentration (Fig. 7), contrary to the expectations of the
buffering model. (b) Rather low temperature dependences (Q,o - 1 .3) are
indicative of buffered diffusion (Armstrong and Lester, 1979), but our most
reliable kinetic data-the zero-concentration intercept ofplots like those of Fig.
7-show a Q,o of ^-3 over the range 6-30°C. A Q1o of 3 is within the range
expected for ligand-protein interactions. Thus, buffered diffusion does not seem
to dominate component 2,-f.
Are the relaxations dominated by the interaction oftrans-2BQ and the recep-
tor? In most ofour experiments (e.g., that of Fig. 7), the cis-2BQ concentration
after a single flash was varied by bathing the cell in varying initial concentrations
ofTPSS-2BQ. Other experiments were simply conducted at a fixed TPSS-2BQ
concentration; relaxations were measured as a series of UV flashes converted
the solution to the CPSS (Krouse, 1984). The rate constants increased during
the series, contrary to the expectation for a model that is similar to Scheme 1
but in which kinetics are dominated by trans-2BQ.
Molecular Rearrangements
In addition to concentrationjump experiments, the light-flash technique makes
possible a unique class ofexperiments in which ligand molecules already bound
to receptors are manipulated photochemically to produce a molecular rearrange-
ment of the ligand-receptor complex (Nass et al., 1978; Lester and Nerbonne,
1982). Because of this direct action, such perturbations generally produce more
rapid responses than do concentration jumps. The response to a molecular
rearrangement does not depend on the direction or amplitude of the bulk
concentration changes, although later events may reflect these changes.
We have no direct information about the photoisomerization efficiency of
bound 2BQ as opposed to 2BQ in solution. Spectral measurements with a
covalently bound azobenzene agonist suggest that such differences are minor
(Sheridan and Lester, 1982); however, in the absence ofrelevant data for 2BQ,
we shall describe the amplitudes of these relaxations in a qualitative fashion.
EXPERIMENTS AT THE CIS-PHOTOSTATIONARY STATE With predominantlyKROUSE ET AL.
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cis-2BQ solutions and unfiltered flashes, the molecular rearrangments were
expected to arise predominantly from cis -> trans photoisomerizations of bound
cis-2BQ molecules, because (a) this isomer binds more strongly to receptors, (b)
it was present in higher concentrations, and (c) cis --* trans flux predominates in
unfiltered flashes (see Table 1). We therefore expected that these experiments
would reveal the kinetics of the trans-2BQ-receptor interaction .
Such flashes did produce increases in the conductance as the newly created
trans-2BQmolecules left the receptors. When acetylcholine and suberyldicholine
were the agonists, the increase occurred with a rate constant that was indistin-
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MS
FIGURE 8 . Visible-flash relaxations at 6°C and -150 mV in the simultaneous
presence of suberyldicholine (3 AM) and 2BQ (1 AM). At the beginning of the trial,
the 2BQ was in the cis-photostationary state. A visible flash (during the second
episode) jumped the cis-2BQ concentration from 0.85 to 0.23 AM. The resulting
conductance increase is dominated by a rapid relaxation called component 11f.
Semilog plots are shown at the top; the relaxation rate constants are nearly equal
for the voltagejump and light-flash relaxations. Experiment 6821T80.
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FIGURE 9.
￿
Laser-flash relaxations at 20°C in the simultaneous presence of car-
bachol (200 AM) and 2BQ (1 AM). The protocol is the same as in Fig. 8. The laser
flashjumpsthe cis-2BQconcentration from 0.85 to 0.20AM . Note that the voltage-
jump relaxations are faster than the light-flash relaxation. See text. Experiment
617T70 .
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guishable (±10%) from that of the voltagejump in the next episode (Fig. 8). At
temperatures of 20 ° C or higher with carbachol as the agonist, the agonist-
receptor interaction was characterized by rate constants greater than ^-2 ms -' .
Under these conditions, the flash-lamp discharge could no longer be considered
instantaneous on the time scale of the relaxations. Therefore, the light-flash
relaxations were evoked with a pulsed laser (Fig. 9). Under these conditions, the
light-flash relaxation was clearly slower than the voltagejump relaxation, which
suggests that the dissociation of trans-2BQ had become rate-limiting.
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[cis-215Q] after
FIGURE 10.
￿
Agonist-induced currents from episodes in the simultaneous presence
of carbachol (1 mM) and 2BQ (2 uM). At the start of each episode, the 2BQ was in
the trans-photostationary state ([cis-2BQj = 0.4 1AM); the relaxations were superim-
posed on a steady agonist-induced current of 5.1 mA/cm 2. The flash was filtered
differently for each episode. See text and Table 1 . Voltage, -150 mV; temperature,
6°C. Experiment 1122T64.
EXPERIMENTS AT THE TRANS-PHOTOSTATIONARY STATE In cells exposed
simultaneously to TPSS-2BQ and to agonist, the kinetics depend strongly on
how the flash is filtered (Fig. 10). As the cis -> trans photoisomerization potency
increases (cf. Table I), the rapid conductance increase, component 11f, is larger.
This result is expected because (a) roughly half of the inhibition is produced by
the 20% of cis-2BQ in TPSS-2BQ, and (b) a flash converts the bound cis-2BQ to
trans-2BQ. Fig. 11 explains how the subsequent slower conductance decrease,
Filter flash 1/T2
S-1
Trace
U(:11 (UV) 0.98 20 a
BG3 (blue) 0.90 10 b
341 interference 0.65 18 c
OG550 (orange) 0.40 - d
None (visible) 0.40 6.1 eKROUSE ET AL.
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component 21-f, is also expected as equilibrium is re-established. An unexpected
finding in the experiment of Fig. 10 is that component 2,-f also becomes slower
as the cis -+ trans photoisomerization potency increases. Although traces a and
b have nearly the same initial and final state, the decrease in trace b occurs with
a rate constant roughly half as large as that of trace a. With unfiltered flashes
(trace e), the relaxation is slowed even further, to a rate constant less than one-
DISCUSSION
FIGURE 11 . Cartoon to explain the relaxation in response to unfiltered flashes
with TPSS-2BQ, as in the experiment of Fig. 10, trace e. The flash did not change
the concentrations of cis- and trans-2BQ in the solution, but the agonist-induced
conductance increased and then decreased back to the initial value. Our simple
scheme neglects the complex stoichiometry of channel activation. T, trans; C, cis;
A, agonist. The experiment begins at equilibrium (a). A flash leads to photoisomer-
ization of 2BQ molecules. Bound cis-2BQmolecules isomerize to trans-2BQ, which
leave the receptor (b), and agonist molecules in solution can then bind to the
unoccupied receptor sites (c). After the agonist binding, the channels open (d),
producing the increase in voltage-clamp current associated with component 1 . After
a normal opening, channels close and agonist molecules dissociate from the receptors
(e). cis-2BQ molecules in solution are free to bind to the vacated sites (f), thus
preventingagonist binding. This decline in the conductance back to the initial state
(g) is associated with component 2.
third that of the UV flash . We do not have a full explanation for this slowing;
possibilities are presented in the Discussion .
This paper completes our investigation of acetylcholine receptors in Electrophorus
electroplaques with photoisomerizable azobenzene derivatives. Previous studies
dealt with agonists and with open channel blockers (Lester and Nerbonne, 1982;248
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Sheridan and Lester, 1982; Nerbonne et al., 1983); the present data describe
inhibition by a competitive antagonist. Like other members of the series, the
2BQ molecule has the important property that the cis and trans isomers differ
in pharmacological potency. We have exploited this property tostudythe kinetics
of the interaction between 2BQ and the receptor; these kinetics have been
interpreted in terms of the molecular rate constants for the association and
dissociation events.
The experiments are somewhat limited by the fact that the two isomers differ
by only a factor of 3 in their apparent affinities for the receptor; therefore, a
concentration jump from zero antagonist activity could not be produced. Also,
it is not possible to obtain reliable data at either very large or very small
concentrations ofthe agonist orantagonist, because these conditions involveonly
small changes ofthe conductance. Nonetheless, it is possible to give a reasonably
consistent kineticand equilibriumdescription ofthe interaction between cis-2BQ
and the receptor.
2BQ as a Competitive Antagonist
The dose-response data, i.e., the parallel shift in the dose-response curves, are
consistent with competitive antagonism as the major action of 2BQ under the
conditions of our studies (concentrations of <<-4 AM and voltages between -60
and -150 mV). As usual with such studies, one needs to exclude the possibility
that 2BQ is only a noncompetitive antagonist, with a large excess of "spare
receptors." We performed a few experiments to show that maximal responses
could in fact be obtained with carbachol even in the presence of 1 AM 2BQ
(Krouse, 1984); more complete studies done previously under the same condi-
tions (Sheridan and Lester, 1977; Lester et al., 1978) showed that the test
concentrations of carbachol used were indeed high enough to reveal any non-
competitive blockade.
In addition, 2BQ does exhibit a form of noncompetitive antagonism, open
channel blockade. However, this complication was not serious, because the rate
of blockade was slow under our conditions and this effect could be subtracted
from the measured agonist-induced currents. If the local anesthetic effect were
significant, light flashes would cause photodissociation ofbound 2BQ molecules
from their binding sites within channels; this would lead to increases in the
current on a submillisecond time scale. Such step increases have been observed
with the light-sensitive acetylcholine channel blocker EW-1 (Lester et al., 1979;
Krouse, M. E., unpublished observations). However, no such step was observed
in our experiments, even at the highest 2BQ concentration (5 AM). It can thus
be concluded that the light-flash relaxations were not distorted by the effects of
open channel blockade. Experiments like that of Fig. 6 suggest, however, that it
would be possible to study this open channel blockade directly by delivering
flashes several seconds after a step to a hyperpolarized voltage.
MODELS FOR THE BINDING REACTIONS The equilibrium binding constant
K; for the 2BQ-receptor interaction was calculated from dose-ratio studies. This
method was originally formulated for a case where (a) the receptor R can beKROUSE ET AL.
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completely inhibited by the binding of a single antagonist molecule 1, and (b)
agonist molecules A bind noncooperatively (see, for instance, Jenkinson, 1960).
However, it is well known that the nicotinic receptor binds two or more agonist
molecules per channel; presumably, each agonist site can bind antagonist mole-
cules as well. A more general scheme, then, would be written:
2I+R+2A ~ k ￿I + AR +A-A2R ~ A2R*
_,
￿
IL
￿
k-s
￿
a
12R
k+5
k+s
I + IR + 2A k
￿
AIR
￿
(2)
The A2R* state has the open channel. Each of the three possible antagonist
binding reactions would influence the experimentally measured inhibition. If all
three antagonist binding reactions have the same equilibrium binding constant
(K;), the dose ratio is simply
D = 1 + [I]/K; ;
i.e., the dose-ratio plots are linear with a slope equal to 1/K;.
For other combinations of dissociation constants, the dose-response curves are
no longer shifted in a parallel fashion by the antagonist (cf. Krouse, 1984); the
complete expression is
[A]/Kj(I + [I]/K5) + [([A]/K1)2(1 + [I]/K5)2 +
D =
￿
(2[A]/Ki + 1)(1 + 2[1]/K4 + [1]2/K4K6)1'/2 .
￿
(4)
2[A]/K, + 1
Even if one confines the measurements to a particular response amplitude, the
dose-ratio plots are nonlinear. The plot is upwardly concave (i.e., has a sigmoid
start) if the affinity constant increases for the second antagonist (1 /K6); the
concavity has the opposite sense if the second binding is weaker than the first.
However, these nonlinearities decrease as the level of activation increases and
they would be quite small for our experimental results, which were taken near
the half-maximal response (Colquhoun, 1973). The relationship between antag-
onist binding sites and the shape of the dose-ratio curve has also been addressed
by Pennefather and Quastel (1981). The departures from linearity in our
equilibrium data do suggest a slight upward concavity (cf. Fig. 4), so that one
would suspect a tighter second binding. This observation does not agree with
the suggestion of Sine and Taylor (1981) that there are pre-existing sites of high
and low affinity for antagonists on BC3-H 1 cells. However, our data are insuffi-
ciently precise for a more detailed comparison on this topic. The important point
can be summarized as follows : the K; estimated from the dose-ratio plot is250
determined by the smaller of the two equilibrium dissociation constants, K4 or
K5 .
Kinetic Constantsfor the Interaction Between cis-2BQand the Receptor
The light-flash relaxations are attributed to the binding and dissociation of2BQ.
We now consider the molecular interpretation for such data in terms ofScheme
2 . Fig . 12 shows simulated light-flash relaxations using the protocol of Fig. 6 (a
UV flash producing a relaxation from a low to a high level of inhibition) . The
relaxations are approximately exponential and they are dominated by the antag-
onist-receptor binding step with the largest rate constants . It can therefore be
stated that the relaxation rate constants of Fig . 7 do refer to the faster step ;
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FIGURE 12 .
￿
Simulated concentrationjump relaxations for a UV flash as in the
experiment of Fig . 6. At the time of the flash, the cis-2BQ concentration wasjumped
from 0.2 to 2 AM and the agonist concentration remained constant at 100AM . The
rate constants kt differed for each simulation, but the ratio K4 = k-4/k+4 wasalways
1 AM . The value for k_5 and k_s was 100 s-' and the value for k+5 and k+s was 108
M-' s', so that K5 andK6 also equaled 1 AM . The value of K,, K2, andKs was 100
AM, with instantaneous equilibration at theagonistbinding sites ; a = 3,000 s-'; ,B =
3X10 4 s' .
however, the data do not allow for a choice as to which step (kt4 or kt5) is the
faster .
DISSOCIATION RATE
￿
The theoretical concentration dependence of these
rate constants is shown in Fig. 13A for the simplest possible case, i.e ., all three
antagonist-receptor binding constants are equal. The calculations confirm that
the zero-concentration intercept is the rate constant for dissociation of the
antagonist-receptor complex . The plots have a sigmoid start, however, so that
extrapolations from the linear portion would give underestimates of the true
dissociation rate constant . Therefore, the estimated dissociation rate constants
for cis-2BQ (60 s- ' at 20'C and 11 s- ' at 6°C) may be too small by 10-20% .
ASSOCIATION RATE The model relaxations also predict the variation in
relaxation rate constants with agonist concentration . Here the point of interest
k4 k_ 4 I/T
(0)
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FIGURE 13. (A) Calculated relation between drug concentrations and the rate
constant of light-flash relaxations. For each agonist concentration, 10 relaxations
like those of Fig. 11 were simulated at varying antagonist concentrations [I]. The
plots should be compared with the experimental data in Fig. 7. The calculations
assume that the three antagonist-receptor interactions have equal rate and equilib-
rium constants (k4 = k5 = ke = 5 x 107 M"' S_' ; k_4 = k_5 = k_6 = 50/s). The other
assumed parameters equal those ofFig. 11 . (B) Data are from experiments, including
that of Fig. 7B, at 20 °C on four cells from a single fish. The straight line is a least-
squares fit, weighted for the errors at each point; , the intercept at zero agonist
concentration is 2 x 108 M-' s-' . See text for discussion.
is the factorf the fractional forward binding rate that results from the rapidly
equilibrating occupation of the antagonist binding site by the agonist. The kinetic
simulations summarized in Fig. 13 reveal thatf can be approximated well by a
simple hyperbolic relation,f= 1/(1 + [A]/K'), where K' depends on k1,, kt2, a,252 THE JOURNAL OF GENERAL PHYSIOLOGY " VOLUME 86 - 1985
and ,B. (An explicit formula is not available for K', which does not in general
equal the agonist concentration giving a half-maximal response.) Therefore,
simple reciprocal plots were used to extrapolate f to unity at zero agonist
concentration; an example of such a plot suggests that the largest measured
slopes, in experiments like those of Fig. 7, are a factor of 1.5-2 less than the
actual forward binding rate constant, k+4 = k+5 = k+6 (Fig. 13B). (This estimate
includes a correction for the fact that the extrapolated value is actually 1/2k+4,
because we assume two equivalent binding sites.) We conclude that k+4 is ^-1 x
108 M-' s-' at 200C and -0.2 X 10' M` s-' at 60C.
COMPARISON WITH EQUILIBRIUM MEASUREMENTS With these estimates of
the binding rate constants for cis-2BQ, we can calculate the ratio k_/k+ to obtain
an equilibrium value of0.6 ,M. This estimate should be considered correct only
to within a factor of 3 because of (a) uncertainties about the actual molecular
model, (b) errors in the extrapolation to zero agonist concentration, and (c)
scatter in thedata themselves. Therefore, the calculated equilibrium value, based
on the kinetic measurements, certainly shows satisfactory agreement with the
equilibrium measurements (K; = 0.3 IM).
Rates ofDrug-Receptor Binding
The present data encourage us to make a few general comments about the rate
constants for ligand bindings at the nicotinic acetylcholine receptor. These rates
have been investigatedover the past decade withvoltagejumpandconcentration-
jump relaxations, as well as with fluorescence and flow-quench methods. There
are still some uncertainties: the biochemical studies might measure binding to
the desensitized rather than to the active state (Heidmann and Changeux, 1979;
Boyd and Cohen, 1980; Prinz and Maelicke, 1984), and the electrophysiological
studies could be measuring a rate-limiting conformational change rather than a
binding (Sheridan and Lester, 1977; Lester et al., 1980; Ogden and Colquhoun,
1983). Nonetheless, there is now general agreement that the agonist-receptor
binding proceeds with a forward rate constant of 108-109 M` s-' at 20°C, with
the bis-quaternary compounds falling in the high end ofthis range. The present
data show that antagonist-receptor binding proceeds with rates about an order
of magnitude smaller. The most direct comparisons involve the concentration-
jump experiments using thephotoisomerizable bis-quaternary azobenzene deriv-
atives. The agonist Bis-Q binds with rates of ^-109 M-' s-' at 20°C (Sheridan
and Lester, 1977; Lester et al., 1980) vs. the value of 108 M-' s' determined
for 2BQ in the present study. These differences in binding rate are probably
small enough to agree with the generally held view that (a) antagonists and
agonists have similar initial steric and coulombic interactions with the receptor's
binding site, but (b) only the latter allow the subsequent conformational changes
that open the channel.
There are exceptions to this pleasing concordance. First, in experiments
analogous to that of Fig. 2, d-tubocurarine decreased both the steady state
activationand the relaxation rateconstant for voltagejump relaxations (Sheridan
and Lester, 1977; Colquhoun and Sheridan, 1982). The usual interpretation of
the d-tubocurarine result is that itequilibrates rapidlywith receptors (severalfoldKROUSE ET AL.
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more rapidly than the agonist itself). This admittedly indirect evidence leads to
the conclusion that d-tubocurarine binds with rates that push the limits ofphysical
possibility. We now think that this apparent anomaly can be explained by a
special combination of equilibrium and kinetic properties (Krouse, M. E., and H.
A. Lester, manuscript in preparation). Second, the so-called "open channel
blockers" seem to bind one or two orders of magnitude more slowly, even when
this binding is accelerated by the membrane field (Adams, 1976; Neher and
Steinbach, 1978). Presumably, the binding site is different from the one under
consideration here-it may be directly within the open channel .
What Are the Ratesfor trans-2BQ?
In contrast to the consistent picture obtained for cis-2BQ, our data do not allow
clear conclusions about the kinetics of the interaction between cis-2BQ and the
receptor. One set of experiments involved component 1 1f, the rapid increase
observed after cis -+ trans photoisomerization of bound 2BQ molecules. To
obtain relaxations that were dominated by the dissociation of trans-2BQ, it was
necessary to employ the most rapidly equilibrating agonist, carbachol, and to use
laser flashes (Fig. 9). From these data, one might infer that the interaction
between trans-2BQ and the receptor proceeds with characteristic times on the
order of 1 ms. However, another set of experiments measured the time required
for the relaxation back to equilibrium after unfiltered flashes at the trans-
photostationary state (Fig. 10). From these data, one might infer that hundreds
of milliseconds are involved. We suspect that both inferences are misleading and
that the actual rates lie between these two extremes. Component 1 1-f probably
does not directly reflect the lifetime of newly created trans-2BQ on the receptor
because (a) the trans-2BQ-receptor complex has received a large amount of
energy from the photon and (b) the ligand may be bound in a different config-
uration (or range of configurations) than if it had entered normally from the
free solution. Thus, the kinetics of this relaxation may not reflect the same
molecular events as the equilibrium studies with trans-2BQ.
We have considered two possible mechanisms for the long relaxations of Fig.
10. (a) In the trans-photostationary solution, the proportion of trans is -80% .
Although the cis isomer exhibits a threefold-greater binding constant, trans-
2BQ-receptor complexes are slightly more numerous. The relaxations are thus
slowed under those conditions where the trans-2BQ-receptor interaction would
be expected to dominate the kinetics. To examine this possibility, we extended
our kinetic model (Scheme 2) to include trans-2BQ-receptor interactions at the
same binding sites that bind agonist and cis-2BQ. We were at first surprised that
the model could not reproduce the observed 3.5-fold slowing, even with the
many free parameters offered by nine states and even if the kinetics for the trans
isomer were 30-fold slower than for the cis isomer. We then realized that the
decrease in conductance is still dominated by the fastest inhibition, that caused
by the cis isomer. Thus, the slow relaxations are not explained by a slow trans-
2BQ-receptor interaction .
(b) Buffered diffusion could play a role in the slowing. The unfiltered flashes,
with a large cis --* trans flux, markedly deplete the synaptic cleft of cis-2BQ, most254
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ofit previously bound to receptors. In order to re-establish equilibrium, cis-2BQ
must therefore diffuse in from the external solution (steps e andfin Fig. 11),
and this diffusion would be slowed by multiple binding.
Rough calculations suggest that the buffering model can easily account for the
slow relaxations. If one begins with the data of Armstrong and Lester (1979,
Fig. 8A) and corrects for the slightly higher affinity of cis-2BQ for the receptor
as compared with d-tubocurarine, one concludes that a relaxation rate constants
as slow as 2 s-' would still be explained by buffered diffusion. The fact that the
relaxations were about threefold faster may arise because (a) some cis-2BQ
molecules do remain within the synaptic cleft during the flash and (b) buffering
is reduced by the agonist-receptor interactions. Thus, we tentatively suggest that
the slow relaxations of Fig. 10 reflect buffered diffusion of cis-2BQ molecules as
they enter the synaptic cleft.
We did not notice the same slowing phenomemon in preliminary experiments
at 20°C. However, if this very slow phase has a rather low temperature depend-
ence, its rate would be near that of the noncompetitive channel block effect.
Thus, the temperature test could not be cleanly applied to decide whether the
slow relaxations are governed by the trans-2BQ-receptor interaction or by
buffered diffusion of cis-2BQ as it re-enters the synaptic cleft.
It would be helpful to have comparable data from a preparation not subject
to buffered diffusion. Because cultured myoballs lack synapses and have a low
receptor density, buffered diffusion is not expected to play a role in the kinetics
of drug action. Light-flash experiments are under way with patch-clamped rat
myoballs (Chabala et al., 1982, 1984; Lester and Chabala, 1984).
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